Tenet Healthcare Corp. (NYSE:THC) registered a -4.98% decrease, still its new closing price is 23.61% up from the company’s 1 year high of 34.08.It posted -4.51% losses in previous 5 sessions and is now the subject of 13 analysts who together assign a hold rating on stock. 1 of Wall Street analysts have an underperform rating; the 0 sells versus 3 buy or better ratings. The 18 stock analysts following this company have an average price target at $24.13, with individual PT in the $13.00-$38.00 range. The shares moved at $17.38, implying that brokerage firms see shares losing about -35.91% in twelve months time.
Tenet Healthcare Corp. (THC) SEC Form 4 News
The stock is getting much attention these days as insiders are adding shares while they posted a 17.12% rise year to date. A Director at Tenet Healthcare Corp. (THC) acquired shares in a transaction closed on Friday November 11, 2016. Rittenmeyer Ronald A bought 15,000 shares in the company at $14.35 each and collected $215,000 in proceeds. Rittenmeyer Ronald A now owns 38,783 shares in the company after this transaction. A Director in the company, WILVER PETER M, disclosed a transaction on Wednesday November 09, 2016 that ended up paying $75,001 from the purchase of 5,000 shares at $15.19 per share.
Tenet Healthcare Corp. (NYSE:THC) Upcoming Results on Tap
Tenet Healthcare Corp. will next provide financial results for the March 2017 quarter. Stock analysts expect it to report per-share earnings of $0.54 in that period. Sales during the quarter are predicted to arrive at $4.94 billion.
Earnings surprise history: Last quarter, the company posted approximately $4.85 billion in revenue and EPS of $0.16. The mean forecast was for $4.78 billion and $0.19 a share, respectively. One quarter earlier, revenue for the stock was at $4.87 billion, with earnings at $0.38/share.
Tenet Healthcare Corp. (THC) Brokerage Update
Tenet Healthcare Corp. (THC) is in Mizuho’s research list so their analyst rating change is noteworthy. These shares were downgraded to Underperform from Neutral by Mizuho, according to news reported on Tuesday November 22, 2016.Another important research note was issued by Raymond James on Thursday November 10, 2016.The firm downgraded THC to Mkt Perform from Outperform. Over the last six months and over the last three months, the shares of Tenet Healthcare Corp. (THC), have changed -43.22% and -16.00%, respectively.